1. Market Research
  2. > Pharmaceutical Market Trends

Building Strong Cross-Functional Medical Affairs Teams

  • May 2015
  • Firstword Pharma
Report ID: 3090971

Summary

Table of Contents




Could your Medical Affairs team be better integrated for more effective cross-functional working that drives performance improvement?

Building Strong Cross-functional Medical Affairs Teams examines how numerous pharma companies are working to leverage the potential of Medical Affairs in today’s healthcare environment.

Gain insights on why cross-functional collaboration is essential in order to meet current and future challenges. Discover how Medical Affairs teams are playing a pivotal role in reshaping pharma business models and structures. Learn from real-world case studies that depict how companies like Astellas, Baxter, Boehringer Ingelheim and Novartis are integrating the Medical Affairs function more fully to achieve better results.

Medical Affairs is now uniquely positioned to provide cross-functional teams with valuable scientific and market knowledge at every stage of the product lifecycle. How can your company best leverage the new opportunities?








Key Benefits


Understand the structure and organisation of integrated Medical Affairs teams and how this impacts operations and performance at a global level/BulletPoint>
Understand the diversity of functions performed by Medical Affairs teams and their role in strategic development at the global medical affairs level/BulletPoint>
Learn which teams Medical Affairs interact with most and how the collaborative approach is best managed through defined cross-functional teams and less formal partnerships/BulletPoint>
Determine the optimal point for Medical Affairs to get involved in a project, and grasp how their role changes during the lifecycle of a product/BulletPoint>
Gain insight into the flow of information between Medical Affairs and other teams and how this is monitored and controlled/BulletPoint>
Find answers to the internal challenges Medical Affairs teams face, as well as challenges posed by changes in the healthcare environment




Gain Answers to Key Questions
How can Medical Affairs be better integrated to become a more powerful force for business success?
How can Medical Affairs teams become more effective internal partners and key participants in cross-functional teams?
How can Medical Affairs be made part of a more holistic, and productive, approach to product lifecycle management?
How are optimal Medical Affairs teams structured, and how do they interact with other teams?
How are some of pharma’s leading players leveraging their Medical Affairs Teams to meet today’s business challenges?



Top Takeaways
Nine case studies of cross-functional Medical Affairs structures and operations based on the knowledge and experience of senior medical affairs professionals
Expert insights into the value Medical Affairs teams bring as internal partners and key participants in cross-functional teams
The challenges and the key drivers of change for the Medical Affairs role is identified, discussed and interpreted
Analysis of the critical challenges faced by Medical Affairs operating in cross-functional team environments, locally and globally
Insights into developing the Medical Affairs as part of a more holistic approach to product lifecycle management


Expert Contributors

Experts Interviewed
Head of Regional Medical Affairs
Vice President, US Medical Affairs
Associate Director, Field Medical Affairs
Executive Medical Director, Medical Affairs
Franchise Head, Medical Communications
Global Medical Affairs Director
Vice President of Medical and Scientific Affairs
Head of Strategic Global Medical Affairs Operations
Experts Interviewed
Actelion
Astellas Pharma
Baxter
Boehringer Ingelheim
Karyopharm
Novartis




About FirstWord Reports

FirstWord is an innovative industry intelligence leader serving over 240,000 Pharma and MedTech professionals worldwide. FirstWord offers a range of products and services designed to help your company gain a competitive edge by making key business decisions with speed and confidence



FirstWord Pharma PLUS is a personalised and comprehensive intelligence service delivering up-to-the-minute pharma news, insight, analysis and expert views of importance to your company’s success.
FirstWord Reports deliver timely, need-to-know intelligence about your products, your competitors and your markets. Covering biosimilars, market access, medical affairs, sales & marketing, technology and therapy areas, FirstWord Reports provide expert views and intelligence on the challenges facing pharma today.


Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Veronica helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Clinical Chemistry Reagents and Analyzers Market 2021: A 74-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 75000
  • Industry report
  • May 2017
  • by Venture Planning Group

This new 74-country report from VPGMarketResearch.com is available by region, country, market segment, section, or individual test. Please contact Client Services at reports@vpgcorp.com or +1 212 564 ...

Cancer Diagnostics Market 2021: A 74-Country Analysis--Supplier Shares and Strategies, Emerging Tumor Markers, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 52400
  • Industry report
  • May 2017
  • by Venture Planning Group

This new 74-country report from VPGMarketResearch.com is available by region, country, market segment, section, or individual test. This report is designed to assist diagnostics industry executives, as ...

Tumor Markers Testing Market 2021: A 74-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Tests, Technologies and Opportunities

  • $ 52400
  • Industry report
  • June 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.